Consumer Goods Manufacturer
manages GLP-1 trends and improves
access to obesity specialty care
Vida has solutions for organizations that cover anti-obesity medications (AOMs) — and those that don’t. One manufacturer opted to launch Vida as a preferred prescriber of AOMs, fully integrated into their PBM for utilization management. They also offered Vida’s preventive and chronic pathways for those not currently on a GLP-1.
The result? The organization saw GLP-1 utilization shift towards lower-cost alternatives while maintaining strong member engagement.
9% of Vida members started on GLP-1s, compared to 40–50% benchmark for unmanaged care
GLP-1 utilization in obesity clinics
The company’s key priorities
Reduce healthcare costs for members with obesity and related conditions
Deliver value-based prescribing care, facilitated by PBM integration
Offer flexibility to balance medication access with cost savings
Engage members in health coaching for behavior change
About the company
This manufacturer has over 25 facilities across North America in both urban and rural areas.
Most members found alternatives to GLP-1s¹
Members were highly engaged¹
11%
of eligible members enrolled in the program
88%
regularly interacted with a Vida coach
40%
of members used Vida more than 5 days a week
¹Outcomes at 4 months post launch
We appreciate that Vida aligned with our goals by not only prescribing both
GLP-1s and appropriate alternatives, but also providing performance guarantees around cost-effectiveness.
– HR leader
